Joseph Jimenez's most recent trade in Century Therapeutics Inc was a trade of 44,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 292 | 33,658 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 246 | 33,229 (0%) | 0% | 0 | Common Stock | |
| GM | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 7,543 | 82,251 | - | - | Deferred Share Units ("DSUs") | |
| GM | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 824 | 83,075 | - | - | Deferred Share Units ("DSUs") | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 276 | 32,858 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 1,309 | 32,463 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 268 | 31,154 (0%) | 0% | 0 | Common Stock | |
| Century Therapeutics Inc | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 284 | 30,776 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 263 | 30,384 (0%) | 0% | 0 | Common Stock | |
| GM | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 9,944 | 73,986 | - | - | Deferred Share Units ("DSUs") | |
| GM | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 722 | 74,708 | - | - | Deferred Share Units ("DSUs") | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 326 | 30,015 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2023 | 1,520 | 29,583 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2023 | 296 | 28,063 (0%) | 0% | 0 | Common Stock | |
| Graphite Bio Inc | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 287 | 27,275 (0%) | 0% | 0 | Common Stock | |
| GM | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 8,076 | 63,755 | - | - | Deferred Share Units ("DSUs") | |
| GM | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 287 | 64,042 | - | - | Deferred Share Units ("DSUs") | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 292 | 26,893 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2022 | 1,610 | 26,510 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2022 | 290 | 24,900 (0%) | 0% | 0 | Common Stock | |
| Graphite Bio Inc | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 299 | 24,535 (0%) | 0% | 0 | Common Stock | |
| Century Therapeutics Inc | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 239 | 24,167 (0%) | 0% | 0 | Common Stock | |
| GM | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 5,816 | 55,679 | - | - | Deferred Share Units | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 253 | 23,865 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2021 | 1,408 | 23,546 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 241 | 22,138 (0%) | 0% | 0 | Common Stock | |
| Century Therapeutics Inc | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 19,872 | 19,872 | - | - | Option (right to buy) | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 260 | 21,841 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2021 | 238 | 21,524 (0%) | 0% | 0 | Common Stock | |
| Graphite Bio Inc | Joseph Jimenez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 13 Jan 2021 | 49,876 | 153,815 | - | 0.3 | 14,963 | Common Stock |
| Graphite Bio Inc | Joseph Jimenez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2021 | 49,876 | 0 | - | - | Stock Option (right to buy) | |
| Graphite Bio Inc | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 49,876 | 49,876 | - | - | Stock Option (right to buy) | |
| Graphite Bio Inc | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 19,763 | 19,763 | - | - | Series B Preferred Stock | |
| Graphite Bio Inc | Joseph Jimenez | Director | 13 Jan 2021 | 19,763 | 0 | - | - | Series B Preferred Stock | ||
| Graphite Bio Inc | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 12,469 | 12,469 | - | - | Stock Option (right to buy) | |
| Graphite Bio Inc | Joseph Jimenez | Director | 13 Jan 2021 | 8,126 | 161,941 | - | - | Common Stock | ||
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 254 | 21,231 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 1,387 | 20,931 (0%) | 0% | 0 | Common Stock | |
| P&G | Joseph Jimenez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2020 | 258 | 19,544 (0%) | 0% | 0 | Common Stock |